Physician profile
Yi Ding
NPI 1114309267
$1,807.02
in general payments reported to CMS, 2019-2025
20 companies · $25.00 in 2025
The $25.00 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.70 · 2020: $30.12 · 2021: $371 · 2022: $869 · 2023: $415 · 2024: $54.27 · 2025: $25.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $494.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $536.90 | 2021-2023 | Senza |
| Amgen INC. | $304.28 | 2021-2022 | |
| Abbvie INC. | $293.16 | 2021-2025 | Botox, Ubrelvy |
| Pfizer INC. | $129.85 | 2023-2024 | |
| Horizon Therapeutics Plc | $59.01 | 2022-2023 | Krystexxa |
| Kerecis Limited | $58.31 | 2019-2022 | |
| Allergan, INC. | $53.09 | 2022 | |
| Lilly USA, LLC | $49.14 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $46.52 | 2022-2024 | Belbuca |
| Boston Scientific Corporation | $44.31 | 2021-2022 | |
| Avanos Medical | $41.24 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $33.74 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $31.88 | 2022-2023 | Zilretta, Iovera |
| Piramal Critical Care | $24.66 | 2019 | |
| Merz Pharmaceuticals, LLC | $23.80 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $20.27 | 2021 | |
| Pacira Therapeutics, INC. | $16.00 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.14 | 2021 | |
| Medtronic, INC. | $13.72 | 2021 | |
| Biodelivery Sciences International, INC. | $13.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yi Ding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.